X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
aged (16) 16
female (16) 16
middle aged (16) 16
cardiac & cardiovascular systems (15) 15
cardiovascular (15) 15
male (15) 15
index medicus (13) 13
percutaneous coronary intervention (11) 11
treatment outcome (11) 11
acute coronary syndromes (8) 8
cardiology and cardiovascular medicine (8) 8
guidelines (8) 8
clopidogrel (7) 7
myocardial infarction (7) 7
aged, 80 and over (6) 6
follow-up studies (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
acute coronary syndrome (5) 5
antiplatelet therapy (5) 5
cardiovascular diseases (5) 5
dosage and administration (5) 5
outcome (5) 5
peripheral vascular disease (5) 5
prospective studies (5) 5
risk factors (5) 5
stents (5) 5
abridged index medicus (4) 4
acute myocardial infarction (4) 4
adult (4) 4
analysis (4) 4
aspirin (4) 4
care and treatment (4) 4
coronary artery disease (4) 4
heart attacks (4) 4
incidence (4) 4
metaanalysis (4) 4
myocardial infarction - diagnosis (4) 4
myocardial infarction - therapy (4) 4
myocardial ischaemia (4) 4
platelet aggregation inhibitors - adverse effects (4) 4
prasugrel (4) 4
registry (4) 4
stable coronary artery disease (4) 4
ticagrelor (4) 4
ticlopidine - analogs & derivatives (4) 4
usage (4) 4
adenosine monophosphate - adverse effects (3) 3
adenosine monophosphate - analogs & derivatives (3) 3
adenosine monophosphate - therapeutic use (3) 3
angioplasty (3) 3
bleeding (3) 3
blood platelets (3) 3
blood pressure monitoring, ambulatory (3) 3
cardiac patients (3) 3
cardiology (3) 3
controlled-trial (3) 3
double-blind method (3) 3
drug therapy (3) 3
drug therapy, combination (3) 3
intervention (3) 3
ischemia (3) 3
kidney - innervation (3) 3
management (3) 3
mortality (3) 3
myocardial infarction - mortality (3) 3
myocardial revascularization (3) 3
optical coherence tomography (3) 3
patient outcomes (3) 3
patients (3) 3
performing operations (3) 3
revascularization (3) 3
risk stratification (3) 3
spironolactone (3) 3
st-segment-elevation (3) 3
thrombosis (3) 3
ticlopidine - adverse effects (3) 3
ticlopidine - therapeutic use (3) 3
transporting (3) 3
trial (3) 3
ablation (2) 2
acute coronary syndrome - mortality (2) 2
acute coronary syndrome - therapy (2) 2
acute myocardial-infarction (2) 2
aggregation (2) 2
aldosterone antagonists (2) 2
ambulatory blood pressure monitoring (2) 2
amiodarone (2) 2
anaesthesiology (2) 2
angina pectoris (2) 2
angina, unstable - diagnosis (2) 2
angina, unstable - therapy (2) 2
angioplasty, balloon, coronary - adverse effects (2) 2
anti-ischaemic drugs (2) 2
anti-thrombotic therapy (2) 2
antihypertensive agents - therapeutic use (2) 2
antithrombotic therapy (2) 2
aortic stenosis (2) 2
aortic valve - surgery (2) 2
artery-bypass-surgery (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1303 - 1313
This clinical trial compared two antiplatelet regimens during PCI: oral clopidogrel and intravenous cangrelor. As compared with clopidogrel, cangrelor resulted... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | METAANALYSIS | TICAGRELOR | CARDIOVASCULAR EVENTS | ACHIEVE OPTIMAL MANAGEMENT | CLOPIDOGREL PRETREATMENT | PRASUGREL | STANDARD THERAPY | ANTIPLATELET THERAPY | STRATEGIES | Double-Blind Method | Ticlopidine - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Adenosine Monophosphate - analogs & derivatives | Hemorrhage - etiology | Intention to Treat Analysis | Myocardial Ischemia - therapy | Ticlopidine - adverse effects | Female | Aged | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects | Thrombosis - mortality | Platelet Aggregation Inhibitors - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Cangrelor | Angioplasty | Patient outcomes | Product/Service Evaluations | Hemorrhage | Risk factors | Control | Ischemia | Dosage and administration | Drug therapy | Myocardial infarction | Adenosine | Heart attacks | Intravenous administration | Thrombosis | Patients | Bleeding | Dyspnea | Implants | Clopidogrel | Acute coronary syndromes | Respiration
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 24, pp. 2330 - 2341
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2018, Volume 71, Issue 4, pp. 371 - 381
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A13551 - A13551
IntroductionMitraClip therapy has become a therapeutic alternative for high surgical risk patients with symptomatic mitral regurgitation (MR). There are... 
Journal Article
Journal Article